Provided By GlobeNewswire
Last update: May 29, 2024
GUANGZHOU, China, May 29, 2024 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology, today reported financial results for the three months ended March 31, 2024.
NASDAQ:BNR (2/21/2025, 8:03:58 PM)
7.15
+0.06 (+0.85%)
Find more stocks in the Stock Screener